Skip to main content
OpenTrials
Completed

NCT Number: NCT04479501

Retrospective Review on Patients With Recurrent Asthmatic Attacks Requiring Hospitalizations

Asthma is a common respiratory disease. around the world. Asthma exacerbation is one of the major sequelae and associated with various morbidity and mortality. A satisfactory asthma control can help to bring down the risk of exacerbation and hence hospitalization. However, the real-world evidence on the clinical factors that leads to multiple admissions, when compared with single admission, due to asthma exacerbation is scarce. This study aimed at evaluating the clinical characteristics of patients who had single and multiple hospitalizations for asthma exacerbations, and exploring the risk factors that predict multiple hospitalizations.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chinese University of Hong Kong

Hong Kong

About this study

Asthma is a common respiratory disease worldwide and in Hong Kong. According to the estimation by the Center for Disease Control and Prevention in 2015, 7.6% adults in the United States have asthma. In Hong Kong, the prevalence of asthma was estimated to be 10.1% among 13 to 14 years old children and 5.8% in randomly selected Chinese elderly aged more than 70. The clinical characteristics varies in different age groups, with elderly asthmatics have higher rates of bronchial hyper-reactivity and more severe phenotypes, when comparing with younger patients. This is more important in an ageing population.

Asthmatic exacerbation is not an uncommon complication and can be fatal. For those patients with near-fatal asthma exacerbation, ICU admission and mechanical ventilation may be necessary to prevent mortality. This is more common among poor controllers and adults. Asthma-related deaths may be reduced if risk factors are recognized and addressed early.

Many predictors for exacerbation had been identified, both endogenous and exogenous, including high eosinophil count, upper airway diseases, gastroesophageal reflux, poor inhaler technique, medication non-compliance, guideline non-compliance. One of the most powerful predictors for future exacerbation in patients with severe or difficult-to-treat asthma is a recent severe asthma exacerbation. In addition, hospitalization for exacerbations requiring ICU care and mechanical ventilation are both predictors for near-fatal asthma. After the acute attack, its unfavourable impact continues and can lead to multiple sequelae. Exacerbation of asthma is associated with a more rapid decline in the post-bronchodilator forced expiratory volume in 1 second and worse quality of life. In addition, individuals with uncontrolled asthma had higher medical expenditures and decreased productivity, contributing to a greater economic burden when compared with individuals without asthma. In contrary, patients with controlled asthma had lower hospitalization rate, mortality rate and less decline in lung function.

Many of these factors are potentially reversible. But, there is still a significant proportion of asthma patients experiencing recurrent exacerbation despite optimization of pharmacological treatment. A model of better asthma care may be established by improving the understanding on these risk factors, leading to less exacerbation events.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients with hospitalization for asthmatic exacerbation according to physician's clinical judgement
  • Age greater than 18 years old

Exclusion criteria

  • Inappropriate diagnosis of asthma exacerbation after evaluation

Treatment and study plan

Asthma exacerbation related hospitalization

Other

Evaluate the difference between patients with single and multiple hospitalizations for asthma exacerbation

Primary outcomes

  1. Number of patients who had hospitalization for asthma attack

    Time frame: 1 year

    Number of patients who had hospitalization for asthma attack

Secondary outcomes

  1. Burden of comorbidity among subjects with recurrent hospital admission for asthma attack

    Time frame: 1 year

    Burden of comorbidity among subjects with recurrent hospital admission for asthma attack

  2. Spirometric parameters (FEV1, FVC) among subjects with recurrent hospital admission for asthma attack

    Time frame: 1 year

    Spirometric parameters (FEV1, FVC) among subjects with recurrent hospital admission for asthma attack

  3. Baseline blood eosinophil among subjects with recurrent hospital admission for asthma attack

    Time frame: 1 year

    Baseline blood eosinophil among subjects with recurrent hospital admission for asthma attack

  4. Prevalence of asthma patients who had received phenotypic workup

    Time frame: 1 year

    Prevalence of asthma patients who had received phenotypic workup

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Collaborators

  • Alice Ho Miu Ling Nethersole Hospital
  • Caritas Medical Centre, Hong Kong
  • Kwong Wah Hospital
  • North District Hospital, Hong Kong
  • Pamela Youde Nethersole Eastern Hospital
  • Princess Margaret Hospital, Hong Kong
  • Queen Elizabeth Hospital, Hong Kong
  • Queen Mary Hospital, Hong Kong
  • Tseung Kwan O Hospital, Hong Kong
  • United Christian Hospital

Registry information

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Jul 21, 2020
Registry last updated
Jul 21, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.